Dental News Roundup - January 2012
BY MATTHEW JAFFE, JANUARY 31, 2012
Earnings
Align Technology announced 4Q:11 net revenues of $128.9 million, up 38.8% from the quarter a year ago and beating analyst estimates by $0.03 per share. Net profit for 4Q:11 was $20.4 million, or $0.25 per diluted share, compared to 4Q:10 net profits of $9.9 million, or $0.13 per diluted share. FY:11 net revenues were $479.7 million, up 23.9% from $387.1 million for FY:10. Net profits for FY:11 were $66.7 million, or $0.83 per diluted share, down from $74.3 million, or $0.95 per diluted share the previous year.
Zimmer reported FY:11 dental sales of $248 million, a 13% increase (12% constant currency) over the previous year. For the fourth quarter, they reported dental sales were $63.5 million, up 2% both as reported in constant currency.
Regulatory
Align has received a Product Registration Certificate from the Federal Service of Health Care and Social Development Control of the Russian Federation. This will allow them to expand sales of Invisalign in to Russia. They are additionally expanding Middle East distribution to from Turkey to include Dubai and Saudi Arabia.
Product Introduction and Update
Align Technology released Invisalign Express 5. It is described as a lower cost option for patients who need five stages of aligners or less for their treatment. A patent uses on average 24 aligners in a year.
Collaborations
Biomet 3i and Sirona have collaborated on Sirona’s CEREC Interoral Scanner to create digital impressions for Biomet’s BellaTek Encode Impression System.
Appointments
Sirona announced that Nicholas W. Alexos and Timothy D. Sheehan were leaving the Board of Directors. After their departure, the board will be formed from three members from the management team and six independent directors.
